A family history of Parkinson's disease and its effect on other PD risk factors

Neuroepidemiology

Volumn 18, Issue 5, 1999, Pages 270-278

  Rybicki, Benjamin A ^a,c   Johnson, Christine C ^a   Peterson, Edward L ^a   Kortshab, Gene X ^a,b   Gorell, Jay M ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Copper; Effect modification; Interaction; Iron; Lead; Metals; Smoking

Indexed keywords

COPPER; IRON; LEAD;

AGE; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; OCCUPATIONAL EXPOSURE; PARKINSON DISEASE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICHIGAN; MIDDLE AGED; OCCUPATIONAL EXPOSURE; ODDS RATIO; PARKINSON DISEASE; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 0032794767     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026222     Document Type: Article

References (44)

1. Veldman BA, Wijn AM, Knoers N, Praamstra P, Horstink MW: Genetic and environmental risk factors in Parkinson's disease. Clin Neurol Neurosurg 1998;100:15-26.
2. Chase TN: A gene for Parkinson's disease. Arch Neurol 1997;54:1156-1157.
3. Nussbaum RL, Polymeropoulos MH: Genetics of Parkinson's disease. Hum Mol Genet 1997;6:1687-1691.
4. Tanner CM, Goldman SM: Epidemiology of Parkinson's disease. Neurol Clin 1996;14:317-335.
5. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Richardson RJ: The risk of Parkinson's disease with exposures to pesticides, farming, well water and rural living. Neurology 1998;50:1346-1350.
6. Seidler A, Hellenbrand W, Robra BP, Vieregge P, Nischan P, Joerg J, Oertel WH, Ulm G, Schneider E: Possible environmental, occupational, and other etiologic factors for Parkinson's disease: A case-control study in Germany. Neurology 1996; 46:1275-1284.
7. Semchuk KM, Love EJ, Lee RG: Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology 1992;42: 1328-1335.
8. Hubble JP, Cao T, Hassanein RE, Neuberger JS, Koller WC: Risk factors for Parkinson's disease. Neurology 1993;43:1693-1697.
9. Liou HH, Tsai MC, Chen CJ, Jeng JS, Chang YC, Chen SY, Chen RC: Environmental risk factors and Parkinson's disease: A case-control study in Taiwan. Neurology 1997; 48:1583-1588.
10. Wechsler LS, Checkoway H, Franklin GM, Costa LG: A pilot study of occupational and environmental risk factors for Parkinson's disease. Neurotoxicology 1991;12:387-392.
11. Hertzman C, Wiens M, Snow B, Kelly S, Calne D: A case-control study of Parkinson's disease in a horticultural region of British Columbia. Mov Disord 1994;9:69-75.
12. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG, Richardson RJ: Occupational exposures to metals as risk factors for Parkinson's disease. Neurology 1997;48:650-658.
13. Zayed J, Ducic S, Campanella G, Panisset JC, Andre P, Masson H, Roy M: Environmental factors in the etiology of Parkinson's disease. Can J Neurol Sci 1990;17:286-291.
14. Ngim CH, Devathasan G: Epidemiologic study on the association between body burden mercury level and idiopathic Parkinson's disease. Neuroepidemiology 1989;8: 128-141.
15. Gerlach M, Ben-Shachar D, Riederer P, Youdim MBH: Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 1994;63:793-807.
16. Langston JW, Ballard P, Tetrud JW, Irwin I: Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983; 219:979-980.
17. Gowers WR: A Manual of Diseases of the Nervous System. Philadelphia, Blakiston, 1893.
18. Bell J, Clark AJ: A pedigree of paralysis agitans. Ann Eugen 1926;1: 445-462.
19. Lazzarini AM, Myers RH, Zimmerman TR, Mark MH, Golbe LI, Sage JI, Johnson WG, Duvoisin RC: A clinical genetic study of Parkinson's disease. Neurology 1994;44:499-506.
20. Plante-Bordeneuve V, Taussig D, Thomas F, Ziegler M, Said G: A clinical and genetic study of familial cases of Parkinson's disease. J Neurol Sci 1995;133:164-172.
21. Maraganore DM, Harding AE, Marsden CD: A clinical and genetic study of familial Parkinson's disease. Mov Disord 1991;6:205-211.
22. Johnson WG: Genetic susceptibility to Parkinson's disease. Neurology 1991;41:82-87.
23. De Michele G, Filla A, Marconi R, Volpe G, D'Alessio A, Scala R, Ambrosio G, Campanella G: A genetic study of Parkinson's diseases. Neural Transm Suppl 1995;45:21-25.
24. Marder K,Tang MX, Mejia H, Alfaro B, Cote L, Louis E, Groves J, Mayeux R: Risk of Parkinson's disease among first-degree relatives: A community-based study. Neurology 1996;46:155-160.
25. Bonifati V, Fabrizio E, Vanacore N, DeMari M, Meco G: Familial Parkinson's disease: A clinical genetic analysis. Can J Neurol Sci 1995;22: 272-279.
26. Payami H, Larsen K, Bernard S, Nutt J: Increased risk of Parkinson's disease in parents and siblings of patients. Ann Neurol 1994;36:659-661.
27. Polymeropoulos MH, Higgins JJ, Golbe LI, Johnson WG, Ide SE, Di Iorio G, Sanges G, Stenroos ES, Pho LT, Schaffer AA, Lazzarini AM, Nussbaum RL, Duvoisin RC: Mapping a gene for Parkinson's disease to chromosome 4q21-q23. Science 1996;274:1197-1199.
28. Bennett P, Nicholl DJ: Absence of the G209A mutation in the alpha-synuclein gene in British families with Parkinson's disease. Neurology 1998;50:1183-1183.
29. Vaughan JR, Farrer MJ, Wszolek ZK, Gasser T, Durr A, Agid Y, Bonifati V, DeMichele G, Volpe G, Lincoln S, Breteler M, Meco G, Brice A, Marsden CD, Hardy J, Wood NW: Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations. The European Consortium on Genetic Susceptibility in Parkinson's disease (GSPD). Hum Mol Genet 1998;7:751-753.
30. Chan P, Tanner CM, Jiang X, Langston JW: Failure to find the alpha-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease. Neurology 1998;50:513-514.
31. Gasser T, Muller-Myhsok B, Wszolek ZK, Oehlmann R, Calne DB, Bonifati V, Bereznai B, Fabrizio E, Vieregge P, Horstmann RD: A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet 1998;18:262-265.
32. Scott WK, Stajich JM, Yamaoka LH, Speer MC, Vance JM, Roses AD, Pericak-Vance MA: Genetic complexity and Parkinson's disease. Deane Laboratory Parkinson Disease Research Group (letter). Science 1997;277:1197-1199.
33. Takakubo F, Yamamoto M, Ogawa N, Yamashita Y, Mizuno Y, Kondo I: Genetic association between cytochrome P450IAI gene and susceptibility to Parkinson's disease. J Neural Transm Gen Sect 1996; 103:843-849.
34. Plante-Bordeneuve V, Davis MB, Maraganore DM, Marsden CD, Harding AE: Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease. J Neurol Neurosurg Psychiatry 1994;57:911-913.
35. Smith CAD, Gough AC, Leigh PN, Summers BA, Harding AE, Maraganore DM, Sturman SG, Schapira AHV, Williams AC, Spurr NK, Wolf CR: Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992;339:1375-1377.
36. Landi MT, Ceroni M, Martignoni E, Bertazzi PA, Caporaso NE, Nappi G: Gene-environment interaction in Parkinson's disease. The case of CYP2D6 gene polymorphism. Adv Neurol 1996;69:61-72.
37. Mutch WJ, Smith WC, Scott RF: A screening and alerting questionnaire for parkinsonism. Neuroepidemiology 1991;10:150-156.
38. Folstein M, Folstein S, McHugh PR: Mini-mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
39. DeMichele G, Filla A, Volpe V, DeMarco V, Gogliettino A, Ambrosio G, Marconi R, Castellano AE, Campanella G: Environmental and genetic risk factors in Parkinson's disease: A case-control study in southern Italy. Mov Disord 1996;11:17-23.
40. Ho SL, Kapadi AL, Ramsden DB, Williams AC: An allelic association study of monoamine oxidase B in Parkinson's disease. Ann Neurol 1995;37:403-405.
41. Hotamisligil GS, Girmen AS, Fink JS, Tivol E, Shalish C, Trofatter J, Baenziger J, Diamond S, Markham C, Sullivan J, Growdon J, Breakefield XO: Hereditary variations in monamine oxidase as a risk factor for Parkinson's disease. Mov Disord 1994;9:305-310.
42. Hubble JP, Kurth JH, Glatt SL, Kurth MC, Schellenberg GD, Hassanein RE, Lieberman A, Koller WC: Gene-toxin interaction as a putative risk factor for Parkinson's disease with dementia. Neuroepidemiology 1998;17:96-104.
43. Yang Q, Khoury MJ: Evolving methods in genetic epidemiology. III. Gene-environment interaction in epidemiologic research. Epidemiol Rev 1997;19:33-43.
44. Gorell JM, Rybicki BA, Johnson CC, Peterson EL: Smoking and Parkinson's disease: A dose-response relationship. Neurology 1999;52:115-119.